Recent advances in understanding and treating immunoglobulin light chain amyloidosis [version 1; referees: 2 approved]
Immunoglobulin (Ig) light chain (AL) amyloidosis is a clonal plasma cell disorder characterized by misfolded Ig light chain deposition in vital organs of the body, resulting in proteotoxicity and organ dysfunction. Owing to its diverse clinical presentations and a tendency to mimic common medical co...
Main Authors: | Talha Badar, Anita D'Souza, Parameswaran Hari |
---|---|
Format: | Article |
Language: | English |
Published: |
F1000 Research Ltd
2018-08-01
|
Series: | F1000Research |
Online Access: | https://f1000research.com/articles/7-1348/v1 |
Similar Items
-
Recent advances in understanding multiple myeloma [version 1; referees: 4 approved]
by: Binod Dhakal, et al.
Published: (2016-08-01) -
Recent advances in understanding and treating ARDS [version 1; referees: 2 approved]
by: Rebecca M. Baron, et al.
Published: (2016-04-01) -
Recent advances in understanding and treating vasculitis [version 1; referees: 2 approved]
by: Matthew J. Koster, et al.
Published: (2016-06-01) -
Recent advances in understanding and treating nephrotic syndrome [version 1; referees: 2 approved]
by: Agnieszka Bierzynska, et al.
Published: (2017-02-01) -
Recent advances in understanding and treating chronic granulomatous disease [version 1; referees: 4 approved]
by: Andrew Gennery
Published: (2017-08-01)